Hepion Pharmaceuticals Inc. will implement a 1-for-50 reverse stock split, effective at 4:01 p.m. on Monday. The Morristown company’s common stock will begin trading on a split-adjusted basis on March 18 under the same ticker symbol, with a new CUSIP number (426897 401).
The move aims to regain compliance with Nasdaq’s $1 minimum bid price requirement. Approved by stockholders on March 10, the split will reduce outstanding shares from approximately 54.25 million to 1.08 million while maintaining shareholder ownership proportions. No fractional shares will be issued—holdings will be rounded up to the nearest whole share.
Stockholders will receive updated transaction notices from Pacific Stock Transfer Company, while those holding shares through brokers or banks will see automatic adjustments. The split will also proportionally adjust outstanding stock options, warrants, and shares available under Hepion’s stock incentive plans.
